![Paul Firuta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Firuta
Director de Operaciones en
IEcure, Inc.
.
Perfil
Paul Firuta currently works at iECURE, Inc., as Chief Operating Officer from 2021.
Mr. Firuta also formerly worked at OraPharma, Inc., as Director-National Accounts & Reimbursement from 2000 to 2006, NPS Pharmaceuticals, Inc., as President-US Commercial Operations from 2014 to 2015, Shire ViroPharma, Inc., as Vice President & & General Manager-Americas from 2008 to 2014, Achillion Pharmaceuticals, Inc., as Chief Operating Officer & Executive Vice President from 2018 to 2020, Bioblast Pharma Ltd., as Chief Commercial Officer from 2015 to 2016, Lev Pharmaceuticals, Inc., as Vice President-Managed Markets from 2006 to 2008, and uniQure NV, as Chief Commercial Officer from 2016 to 2018.
Mr. Firuta received his undergraduate degree from King's College (Pennsylvania) and Masters Business Admin degree from St. Joseph's University.
Cargos activos de Paul Firuta
| Empresas | Cargo | Inicio |
|---|---|---|
IEcure, Inc.
 IEcure, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage biotechnology company that develops in-vivo gene insertion/editing therapies to treat rare liver disorders | Director de Operaciones | 01/02/2021 |
Antiguos cargos conocidos de Paul Firuta.
| Empresas | Cargo | Fin |
|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | Director de Operaciones | 28/01/2020 |
| UNIQURE N.V. | Corporate Officer/Principal | 01/06/2018 |
Bioblast Pharma Ltd.
 Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 01/05/2016 |
| NPS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2015 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | 01/02/2014 |
Formación de Paul Firuta.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
59
Relaciones de 1er grado
10
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 10 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
OraPharma, Inc.
 OraPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces drugs for oral diseases | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
King's College (Pennsylvania)
 King's College (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Joseph's University
 St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products for the treatment of inflammatory diseases | Health Technology |
uniQure NV
 uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
IEcure, Inc.
IEcure, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage biotechnology company that develops in-vivo gene insertion/editing therapies to treat rare liver disorders | Health Technology |
- Bolsa de valores
- Insiders
- Paul Firuta
Elige MarketScreener 
